Hepatitis G virus and molecular cloning thereof
AssigneeGenelabs Technologies, Inc.
InventorsJungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
Life of this patent
Estimating the term…
Loading patent…
AssigneeGenelabs Technologies, Inc.
InventorsJungsuh P. Kim, Kirk E. Fry, LaVonne Marie Young, Jeffrey M. Linnen, John Wages
Estimating the term…
Polypeptide antigens are disclosed which are immunoreactive with sera from individuals having a non-A, non-B, non-C, non-D, non-E Hepatitis, herein designated Hepatitis G Virus (HGV). Corresponding genomic-fragment clones containing polynucleotides encoding the open reading frame sequences for the antigenic polypeptides are taught. The antigens are useful in diagnostic methods for detecting the presence of HGV in test subjects. The antigens are also useful in vaccine and antibody preparations. In addition, the entire coding sequences of two HGV isolates are disclosed. Methods are presented for nucleic acid-based detection of HGV in samples and also methods for the isolation of further genomic sequences corresponding to HGV.
A purified antibody preparation made against a polypeptide of SEQ ID NO:
A method for producing an antibody to Non-A Non-B Non-C Non-D Non-E Hepatitis G Virus (HGV), comprising
Dependencies are inferred from the claim text.